IGF/IGFBPs level alterations in MetS have been, to some extent, observed, however the exact mechanism has not been elucidated—still it suggests a trend towards IGF-1 local or systemic deficiency or availability. This evidence concerns the gene IGF1 and metabolic syndrome.